Involvement of hepatocyte growth factor (HGF) in lung morphogenesis and regeneration has been established by in vitro and in vivo experiments in animals. In the present study, the protective activity of HGF against tumor necrosis factor (TNF)-␣ or hydrogen peroxide (H 2 O 2 )-induced damage of pulmonary epithelial cells was examined using the human small airway epithelial cell line (SAEC). Western blot analysis revealed that the receptor for HGF (c-Met) was highly expressed on the surface of SAEC and its downstream signal transduction pathway was functional. The SAEC was induced into apoptosis by the treatment with TNF-␣ or H 2 O 2 in a dose-dependant manner, but was significantly rescued from apoptosis in the presence of HGF. The HGF effect was evident when added not only at the same time but also within several hours after treatment. This protective activity of HGF against the TNF-␣-or H 2 O 2 -induced apoptosis was mediated, at least in part, by up-regulating the nuclear factor B activity and an increase in the ratio of apoptosis-suppressing to apoptosis-inducing proteins. These results suggest that administration of HGF might exhibit a potent function in vivo for protection and improvement of acute and chronic lung injuries induced by inflammation and/or oxidative stress. Lung development and morphogenesis begin in the fetal period of embryo and finally reach the formation of mature alveolar cells around 36 wk of gestation. The control of lung development is complicated and known to be influenced by the interaction between pulmonary epithelial and mesenchymal cells, which is mainly mediated by autocrine and paracrine mechanisms via a variety of polypeptides expressed on or secreted from mesenchymal cells (1).
Involvement of hepatocyte growth factor (HGF) in lung morphogenesis and regeneration has been established by in vitro and in vivo experiments in animals. In the present study, the protective activity of HGF against tumor necrosis factor (TNF)-␣ or hydrogen peroxide (H 2 O 2 )-induced damage of pulmonary epithelial cells was examined using the human small airway epithelial cell line (SAEC). Western blot analysis revealed that the receptor for HGF (c-Met) was highly expressed on the surface of SAEC and its downstream signal transduction pathway was functional. The SAEC was induced into apoptosis by the treatment with TNF-␣ or H 2 O 2 in a dose-dependant manner, but was significantly rescued from apoptosis in the presence of HGF. The HGF effect was evident when added not only at the same time but also within several hours after treatment. This protective activity of HGF against the TNF-␣-or H 2 O 2 -induced apoptosis was mediated, at least in part, by up-regulating the nuclear factor B activity and an increase in the ratio of apoptosis-suppressing to apoptosis-inducing proteins. These results suggest that administration of HGF might exhibit a potent function in vivo for protection and improvement of acute and chronic lung injuries induced by inflammation and/or oxidative stress. Lung development and morphogenesis begin in the fetal period of embryo and finally reach the formation of mature alveolar cells around 36 wk of gestation. The control of lung development is complicated and known to be influenced by the interaction between pulmonary epithelial and mesenchymal cells, which is mainly mediated by autocrine and paracrine mechanisms via a variety of polypeptides expressed on or secreted from mesenchymal cells (1) .
HGF, which was originally purified and cloned as a potent mitogen for mature hepatocytes in primary culture (2) (3) (4) , is a cytokine mainly produced by cells of mesenchymal origin (5) . Previous studies have demonstrated that HGF has multifunctional activities such as mitogenic, morphogenic, and motogenic on a variety of epithelial cells (5, 6) , including pulmonary epithelial cells (7) . Pulmonary mesenchymal cells synthesize and secrete HGF, which has been shown to be involved not only in the formation of bronchoalveolar structure during fetal development, but also in the repair process of injured distal organs such as liver and kidney (7) (8) (9) (10) . In the bleomycin-induced lung injury model in rats (11) , HGF showed the proliferative effect on type II alveolar epithelial cells, but showed the antiproliferative effect on alveolar macrophages and fibroblasts mainly implicated in the occurrence of fibrotic changes of the lung. In addition, it has recently been shown that endogenous and exogenous HGF protects cardiac myocytes in a rat model of ischemia/reperfusion injury (12) and that the addition of HGF in the culture effectively protects adult rat cardiac myocytes from oxidative stress-induced apoptosis (13) . Thus, it is speculated that HGF might play a role in the physiologic repair process of respiratory epithelium after acute and chronic lung injuries.
The purpose of this study is to evaluate the rescue effect of HGF on pulmonary epithelial cells damaged by inflammation or oxidative stress using the SAEC. We showed that SAEC expressed the receptor for HGF at high levels and was significantly protected from the TNF-␣-or H 2 O 2 -induced apoptosis nM EDTA, 1 mM PMSF, 0.2 TIU/mL aprotinin, 1 g/mL pepstatin A, and 10 mM iodoacetamide) for 30 min on ice as described previously (14) . Sodium vanadate (100 M) was also included in the lysis buffer in tyrosine phosphorylation experiments. The cell lysates were separated on a 7.5-12.5% SDS-polyacrylamide gel under reducing conditions, transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH, U.S.A.), and were incubated with the primary antibodies against Bcl-2 family members (Bcl-2, Bcl-xL, and Bax) overnight at 4°C followed by an incubation with horseradish peroxidase-conjugated second antibody for 1 h at room temperature. The detection of bands was performed using an enhanced chemiluminescence (ECL) kit (Amershan Japan, Tokyo, Japan). Changes in tyrosine phosphorylation of c-Met and Gab1 after HGF treatment was also pursued on Western blot using the specific antibody after immunoprecipitation by antiphosphotyrosine (PT) MAb and protein A beads.
EMSA. EMSA of the NF-B activity was performed according to the method previously described (15) . Before nuclear extraction, 5 ϫ 10 5 cells were cultured with or without TNF-␣ (40 ng/mL) or H 2 O 2 (85 M) in the absence or presence of HGF (40 ng/mL) for 48 h and then harvested. Ten micrograms of nuclear extracts were incubated in a 25 L volume containing 5 L of binding buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 4% glycerol), 0.05 mg/mL nonspecific competitor DNA followed by an addition of 32 P-labeled NF-B-specific oligonucleotide (5'-AGTTGAGGGGACTTTCCCAGGC-3') for 20 min on ice. In the competitive inhibition experiments, 100-fold molar excess of the unlabeled consensus or 1 bp mismatched oligonucleotide (5'-AGTTGAGGCGACTTTCCCAGGC-3') was added to the reaction mixture of nuclear extracts. For supershift analysis, anti-NF-B p50 antibody was added to the nuclear extract and incubated for 30 min before the binding reaction. The samples were loaded on a 6% nondenaturing polyacrylamide gel and subjected to electrophoresis.
Morphologic examination. The cells were cultured for 48 h in the chamber slide (Nalge Nunc International, Naperville, IL, U.S.A.) with TNF-␣ (40 ng/mL) or H 2 O 2 (85 M) in the absence or presence of HGF (40 ng/mL), stained with WrightGiemsa solution, and observed under microscopy.
Statistics. Differences in viability (%) between culture conditions were analyzed by paired t test and repeated-measures ANOVA (Scheffe's method) in Stat-View software (version 5; Abacus Concepts, Berkeley, CA, U.S.A.). The p value Ͻ0.05 was considered significant. c-Met is known to be phosphorylated at two tyrosine sites-1349 and 1356 in the C-terminal of the ␤-subunit-after HGF stimulation (16) . Therefore, we next examined changes in tyrosine phosphorylation of c-Met after HGF treatment on Western blot. As shown in Figure 1B (upper), tyrosinephosphorylation of c-Met was only modest before stimulation, but markedly up-regulated 30 s after HGF stimulation. The tyrosine phosphorylation of c-Met is known to be followed by activation of multiple signal transducers, including the docking protein Gab1, phosphatidyl inositol 3-kinase, the transcriptional factor STATs, and the adaptor protein SHC (17) (18) (19) (20) (21) . Because it is shown that Gab1 activation via its tyrosine phosphorylation plays a central role in the HGF signaling (20, 21) , we examined changes in tyrosine phosphorylation of Gab1 in SAEC after HGF stimulation. As shown in Figure 1B (lower), Gab1 was strongly tyrosine phosphorylated upon stimulation, and its phosphorylation reached the maximal level at 1 min. Theses results indicate that the receptor for HGF is constitutively and highly expressed on the surface of SAEC and its downstream signal transduction pathway is functional.
RESULTS

SAEC
HGF significantly inhibited the TNF-␣-induced cell death in SAEC. We next addressed a protective activity of HGF against the TNF-␣-induced cell death in SAEC. For this purpose, the cells were incubated with or without different concentrations (20, 40 , and 80 ng/mL) of TNF-␣ in the absence or presence of different concentrations (20, 40 , and 80 ng/mL) of HGF for different culture periods (24 and 48 h). Percentages of viable cells were counted by dye exclusion test in each experiment. As shown in Figure 2A , when cultured for 48 h in the absence of HGF, the viability significantly decreased by the treatment with TNF-␣ in a dose-dependent manner (from 85.7 Ϯ 3.0% to 53.3 Ϯ 5.1% at 80 ng/mL of TNF-␣), but, it was significantly recovered in the presence of HGF (40 ng/mL) from 72.6 Ϯ 3.0% to 79.3 Ϯ 3.5% at 20 ng/mL of TNF-␣, from 60.3 Ϯ 5.5% to 75.6 Ϯ 1.5% at 40 ng/mL, and from 53.3 Ϯ 5.1% to 68.2 Ϯ 7.7% at 80 ng/mL. When cultured at 40 ng/mL of TNF-␣, a significant inhibition of cell death by the addition of 40 ng/mL of HGF was observed up to 48 h of culture period (Fig. 2B) . When cultured for 48 h at 80 ng/mL of TNF-␣, a significant inhibition of cell death was documented by the addition of HGF in a dose-dependant fashion (up to 40 ng/mL) (Fig. 2C ). These results indicate that HGF has a protective activity against the TNF-␣-induced cell death in SAEC.
HGF significantly inhibited the hydrogen peroxideinduced cell death in SAEC. We next addressed whether HGF also has a protective activity against H 2 O 2 -induced cell death in SAEC. For this purpose, the cells were incubated with or without different concentrations (85, 170, and 340 M) of H 2 O 2 in the absence or presence of different concentrations (20, 40 , and 80 ng/mL) of HGF for different culture periods (24 and 48 h). When cultured for 48 h in the absence of HGF, the viability significantly decreased in a dose-dependant fashion of H 2 O 2 , but it was significantly recovered by the addition of HGF (40 ng/mL) as follows: from 49.6 Ϯ 6.4% to 67.6 Ϯ 4.0% at 85 M H 2 O 2 , from 44.3 Ϯ 2.5% to 58.6 Ϯ 5.6% at 170 M H 2 O 2 , and from 27.6 Ϯ 2.5% to 44.0 Ϯ 7.8% at 340 M H 2 O 2 ( Fig. 3A) . A significant inhibition of cell death by HGF was observed up to 48 h when cultured at 170 M H 2 O 2 in the presence of 40 ng/mL of HGF ( Fig. 3B ) and in a dosedependant manner of HGF (up to 40 ng/mL) when cultured for 48 h at 340 M H 2 O 2 (Fig. 3C) . These results indicate that HGF protects SAEC from oxidative stress-induced cell death. 
ACTIVITY OF HGF AGAINST SAEC APOPTOSIS
HGF protects SAEC from TNF-␣-or H 2 O 2 -induced cell death when added within several hours after treatment. To examine the protective activity of HGF when added after treatment with TNF-␣ or H 2 O 2 , HGF (40 ng/mL) was included in the culture simultaneously and 1, 3, and 6 h after treatment with TNF-␣ (40 ng/mL) or H 2 O 2 (85 M), and the viability of SAEC was evaluated after 24 and 48 h incubation. As shown in Figure 4 , a significant protective activity was observed after both 24 and 48 h incubation whenever HGF was included in the culture after treatment with TNF-␣ or H 2 O 2 . Importantly, the protective activity of HGF did not decline when HGF was added within 6 h from the start of TNF-␣ treatment, and within 3 h from the start of H 2 O 2 treatment. These results indicate that HGF exerts a protective activity in SAEC even after the death signal delivered from TNF-␣ or H 2 O 2 is fully transmitted to cells.
Protective activity of HGF in SAEC is mediated by mainly inhibiting apoptosis but not necrosis. The dye exclusion test might detect cell death by either apoptosis or necrosis or both. We attempted to tentatively address whether the protective activity of HGF against cell death of SAEC is mediated by the inhibition of apoptosis or necrosis. When the cells were incubated for 24 h with 780 M H 2 O 2 , whose concentration is known to induce necrosis of a variety of cells, in the absence of presence of HGF (40 ng/mL), the protective activity of HGF was no longer observed; 16.0 Ϯ 2.0% of viability in the absence of HGF and 15.0 Ϯ 1.0% in the presence of HGF. In contrast, when the cells were incubated for 24 h with 25 nM staurosporine, which is reported to induce apoptosis of human vascular endothelial cells (22) , in the absence of presence of HGF (40 ng/mL), the marked protective activity of HGF was documented; 26.8 Ϯ 6.3% of viability in the absence of HGF versus 73.0 Ϯ 2.6% in the presence of HGF. These results suggest that the protective activity of HGF in SAEC might be mediated by mainly inhibiting apoptosis but not necrosis.
HGF protected SAEC from apoptosis induced by TNF-␣ or hydrogen peroxide. It is known that ligation of type I receptor (TNF-R1) by TNF-␣ results in recruitment of a cytoplasmic adaptor molecule FADD via TRADD to the death domain of the receptor, leading to activation of caspase-8, which subsequently initiates proteolytic activation of downstream effector caspases such as caspase-3 and -7, and finally induces apoptosis (23) . It is also known that oxidative stress induces a variety of cells into apoptosis by several apoptosisinducing mechanisms such as activation of extracellular signalregulated kinases including c-jun-N-terminal kinase (JNK) and p38, up-regulation of apoptosis-inducing proteins expression, and down-regulation of the NF-B activity (24 -26) . To further biologically assess a decrease in cellular viability of SAEC after TNF-␣ or H 2 O 2 treatment and its partial restoration by the addition of HGF, we performed apoptosis detection analysis with a flow cytometer using FITC-conjugated annexin-V and PI as shown in Figure 5 . When the cells were treated with TNF-␣ (40 ng/mL) and H 2 O 2 (85 M), respectively, in the absence of HGF, the apoptotic population stained with both FITC and PI reached 42.1% and 32.9%, respectively, which decreased to 16.9% and 17.5%, respectively, in the presence of HGF (40 ng/mL). These results suggest that HGF exerts an antiapoptotic function against the TNF-␣-or H 2 O 2 -induced apoptosis in SAEC.
HGF protected SAEC with distinct morphologic changes from the TNF-␣ or H 2 O 2 -induced apoptosis. To evaluate the inhibition mechanism of apoptosis by HGF, we first observed morphologic changes of SAEC in the absence or presence of HGF (40 ng/mL) after 48 h treatment with TNF-␣ (40 ng/mL) or H 2 O 2 (85 M) (Fig. 6) . The cells growing in the SAGM culture medium were adherent to plastic and round in shape (Fig. 6A) . The addition of HGF alone did not affect shape, viability, and proliferative activity of SAEC (Fig. 6B) . After TNF-␣ or H 2 O 2 treatment, the cells markedly lost their adherent activity and showed features characteristic of apoptosis such as cell shrinkage and fragmented nuclei (Fig. 6, C and E) . Of interest, the cells rescued from the TNF-␣-induced apoptosis by HGF were strongly stretched into a fibroblast-like appearance (Fig. 6D) , whereas most cells rescued from the H 2 O 2 -induced apoptosis by HGF remained round in shape (Fig. 6F) . Even when HGF was added several hours after treatment with TNF-␣ or H 2 O 2 , morphologic features were almost identical (data not shown).
Anti-apoptotic activity of HGF was mediated by, at least in part, up-regulation of the NFB activity and altered expression of Bcl-2 family members. It is known that TNF-␣ transmits not only the death signal mediated by the death domain of the receptor, but also the survival signal by up-regulating the endogenous NF-B activity via the interaction of the receptor with adaptor proteins such as RIP and TRAF2, and that whether cells are induced into apoptosis or remain surviving is regulated by the balance between the death and survival signals (23) . It is also known that oxidative stress down-regulates the NF-B activity by suppressing breakdown of IB (inhibitor of NF-B) (27) . Therefore, to shed light on the mechanism of a protective activity of HGF against the TNF-␣ or H 2 O 2 -induced apoptosis, we examined the effect of HGF (40 ng/mL) on the DNA-binding activity of NF-B using EMSA. In untreated SAEC, HGF did not show a significant effect on the NF-B activity (Fig. 7A) . However, as shown in Figure 7B , the slightly increased NF-B activity after treatment with 40 ng/mL of TNF-␣ (lanes 5-8) was modestly but further up-regulated by the addition of HGF (lanes 9 -12). As shown in Figure 7C (longer exposure), treatment with H 2 O 2 (85 M) inhibited the NF-B activity (lanes [5] [6] [7] [8] , but the addition of HGF moderately canceled its inhibition (lanes 9 -12), although supershift of the band by anti-p50 antibody was incomplete (lane 12), suggesting that subunit(s) other than p50 also participate in an increase in the NF-B activity by HGF. These results suggest that up-regulation of the NF-B activity is implicated in a protective activity of HGF on the TNF-␣-or H 2 O 2 -induced apoptosis.
Susceptibility of normal and cancer cells to induction of apoptosis is regulated by the balance of expression between apoptosis-suppressing and apoptosis-inducing proteins. Antiapoptotic proteins such as Bcl-2 and Bcl-XL that reside in the outer mitochondrial membranes inhibit activation of caspase-3 by preventing release of cytochrome c, whereas apoptosis-inducing proteins such as Bax and Bad induce its release by counteracting antiapoptotic proteins (28, 29) . We next examined changes in expression of these molecules on Western blot after 48 h culture with or without TNF-␣ (40 ng/mL) or H 2 O 2 (85 M) in the absence or presence of HGF (40 ng/mL). As shown in Figure 8 , the Bcl-2 expression modestly increased after TNF-␣ or H 2 O 2 treatment alone, and further up-regulated in the presence of HGF. The Bcl-XL expression was unchanged after H 2 O 2 treatment alone, but moderately up-regulated in the presence of HGF. In contrast, the Bax expression was unchanged after TNF␣treatment alone, but markedly down-regulated in the presence of HGF. HGF treatment alone did not affect the expression of these Bcl-2 family proteins (data not shown). Accordingly, the Bcl-2/Bax ratio of 1.7 after TNF-␣ treatment alone increased to 5.5 in the presence of HGF, and the Bcl-X L /Bax ratio of 0.7 after H 2 O 2 treatment alone increased to 1.1 in the presence of HGF. Thus, a protective activity of HGF against the TNF-␣-or H 2 O 2 -induced apoptosis might be mediated, at least in part, by an increase in the ratio of apoptosis-suppressing to apoptosis-inducing proteins.
DISCUSSION
In the present study, we used SAEC as the in vitro model cell line to study the damage and repair of human bronchiolar epithelium, and TNF-␣ and H 2 O 2 as effector mediators to mimic inflammation and oxidative stress, respectively. Airway mucosal inflammation plays a critical role in the pathogenesis of lower respiratory tract infections affecting mainly small bronchi and terminal respiratory airway, and TNF-␣ is one of the key mediators involved in the inflammatory responses (30, 31) . Respiratory syncytial virus often infects infants less than 1 y of age and induces severe bronchiolitis, which is characterized by destruction of bronchiolar epithelium, hypersecretion of mucous, and round cell infiltration resulting in the cultured for 48 h in the absence (lanes 1-4) or presence (lanes 5-8) of HGF (40 ng/mL). Nuclear extracts were incubated with (lanes 4 and 8) or without (lanes 1-3 and 5-7) anti-p50 antibody in the absence (lanes 1 and 5) or presence of 100-fold excess of unlabeled consensus (C; lanes 2 and 6) or mismatched (M; lanes 3 and 7) NF-B oligonucleotide followed by the addition of 32 P-labeled NF-B-specific oligonucleotide. (B) Effect of HGF on the NF-B activity after TNF-␣ treatment. SAEC was cultured for 48 h without (lanes 1-4) or with (lanes 5-12) TNF-␣ in the absence (lanes 1-8) or presence (lanes 9 -12) of HGF (40 ng/mL). Nuclear extracts were incubated with (lanes 4, 8, and 12) or without (lanes 1-3, 5-7, and 9 -11) anti-p50 antibody in the absence (lanes 1, 4, and 9 ) or presence of 100-fold excess of unlabeled consensus (C; lanes 2, 6, and 10) or mismatched (M; lanes 3, 4, 7, 8, 11 , and 12) NF-B oligonucleotide followed by the addition of 32 P-labeled NF-Bspecific oligonucleotide. (C) Effect of HGF on the NF-B activity after H 2 O 2 treatment. SAEC was cultured for 48 h without (lanes 1-4) or with (lanes 5-12) H 2 O 2 in the absence (lanes 1-8) or presence (lanes 9 -12) of HGF (40 ng/mL). Nuclear extracts were incubated with (lanes 4, 8, and 12) or without (lanes 1-3, 5-7, and 9 -11) anti-p50 antibody in the absence or presence of 100-fold excess of unlabeled consensus (C; lanes 2, 6, and 10) or mismatched  (M; lanes 3, 4, 7, 8, 11, and 12 ) NF-B oligonucleotide followed by the addition of 32 P-labeled NF-B-specific oligonucleotide. formation of mucous plugs obstructing bronchioles in the process of which several inflammatory cytokines are closely implicated (32) . On the other hand, hyperoxic lung injury is characterized by a cell-death response with features of apoptosis and necrosis at the level of bronchi, bronchioles, and alveoli, and is considered as one of important factors associated with the pathogenesis of chronic lung disease (CLD), previously called bronchopulmonary dysplasia, which mainly affects premature infants requiring mechanical ventilation and supplemental oxygen (33) . Major features of CLD are metaplastic and/or dysplastic changes with focal emphysematous alveoli, alveolar septal fibrosis, and destruction of bronchiolar epithelium.
In animals, levels of HGF mRNA have been shown to increase in whole lung after injury caused by intratracheal instillation of hydrochloric acids or the ischemia-reperfusion procedure (34, 35) . In humans, serum levels of HGF in pneumonia patients are significantly elevated before treatment, but decrease in those responding to the initial antibiotic therapy, whereas they remain unchanged or further increase in those not responding to the therapy, suggesting that HGF may act as an early therapeutic predictor in pneumonia (36, 37) . HGF is also elevated in the bronchoalveolar lavage (BAL) fluid from acute respiratory distress syndrome patients with a poor prognosis, but not with a good prognosis, suggesting that HGF concentration in the BAL fluid reflects the severity of lung damage (38) . Thus, HGF is physiologically secreted from damaged pulmonary mesenchymal cell and might be involved in the repair process of pulmonary mesenchymal and epithelial cells in a paracrine and/or autocrine fashion.
In the animal models suffering from drug-induced fulminant hepatitis and liver cirrhosis, in vivo transfer of HGF has been shown to have a potent protective activity against liver damage (39) , which was also proved in the HGF gene therapy (40) . However, little is known about the protective effect of exogenously administered HGF on lung damage in humans. We thus addressed the HGF effect on the TNF-␣-or H 2 O 2 -induced small airway damage using the SAEC cell line, and demonstrated that treatment with TNF-␣-or H 2 O 2 -induced SAEC into apoptosis in a dose-dependant manner, but the addition of HGF partially but dose-dependently protected SAEC from apoptosis. Moreover, this protective activity of HGF was evident even if added after initiation of treatment with TNF-␣ or H 2 O 2 , raising the possibility that administration of HGF might be clinically effective for lung injuries by inflammation and/or oxidative stress even after the damages are already proceeding. Of interest, rescued cells by HGF from the TNF-␣-and H 2 O 2 -induced apoptosis showed different shapes, respectively, suggesting that HGF transmits distinct survival signals depending on apoptotic stimuli. Clarification of mechanism of morphologic changes might be important to understand survival signals delivered from HGF and remains for future study.
We also demonstrated that the rescue effect of HGF on the TNF-␣-or H 2 O 2 -induced apoptosis is mediated, at least in part, by up-regulating the NF-B activity and an increase in the ratio of apoptosis-suppressing to apoptosis-inducing proteins expression. Uncontrolled up-regulation of the NF-B activity has been regarded as one of important factors involved in exacerbation of systemic or organ-specific inflammatory diseases (41, 42) , and anti-inflammatory gene therapy to inhibit the NF-B activity is expected to have a beneficial effect on these diseases (43) . We showed that HGF did not affect the NF-B activity in intact SAEC, but selectively up-regulated its activity in SAEC triggered into undergoing apoptosis by TNF-␣, suggesting that administration of HGF to patients with inflammatory diseases will not increase the risk of inflammation spreading into surrounding tissues. Fibrotic changes of alveoli and bronchioles in the repair process from lung injuries plays a crucial role in the pathogenesis of chronic fibrous lung diseases, including CLD in infants. It is reported that TGF-␤, a central mediator of fibrosis, negatively regulates HGF secretion from mesenchymal cells and inhibits regeneration of damaged pulmonary epithelial cells by counteracting HGF activity (44) , suggesting that administration of HGF will contribute to block the progression of fibrotic changes and to regenerate pulmonary epithelial cells in CLD infants. Thus, HGF is expected to have a potent protective activity in vivo against acute and chronic lung injuries induced by inflammation and/or oxidative stress.
A therapeutic approach for obstructive arterial diseases using HGF gene therapy is now clinically under preparation because it has been demonstrated that HGF has a potent angiogenic activity in vitro and in vivo (45) . HGF is expected to be clinically applicable in the near future in a wide range of 
